Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

anemarsaponin B

Copy Product Info
😃Good
Catalog No. T7030Cas No. 139051-27-7

Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway. Anemarsaponin B can inhibit PAF-induced rabbit platelet aggregation in vitro.

anemarsaponin B

anemarsaponin B

Copy Product Info
😃Good
Purity: 99.11%
Catalog No. T7030Cas No. 139051-27-7
Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway. Anemarsaponin B can inhibit PAF-induced rabbit platelet aggregation in vitro.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$84In StockIn Stock
5 mg$196In StockIn Stock
10 mg$295In StockIn Stock
25 mg$497In StockIn Stock
50 mg$723-In Stock
1 mL x 10 mM (in DMSO)$327In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.11%
Appearance:Solid
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

anemarsaponin B AI Summary
anemarsaponin B demonstrates significant hypoglycemic activity in diabetic mice. In one assay, it reduced blood glucose levels by 82.8% at a dose of 50 mg/kg after 6 hours. Additionally, it exhibited an ID50 of 4.33 mg/kg, indicating that this dose effectively reduced blood glucose levels by 50% after 6 hours..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway. Anemarsaponin B can inhibit PAF-induced rabbit platelet aggregation in vitro.
Chemical Properties
Molecular Weight903.06
FormulaC45H74O18
Cas No.139051-27-7
SmilesCC12C(C3C(CC1)C4(C)C(CC3)CC(OC5C(OC6OC(CO)C(O)C(O)C6O)C(O)C(O)C(CO)O5)CC4)CC7C2C(C)=C(CCC(COC8OC(CO)C(O)C(O)C8O)C)O7
Relative Density.1.43 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 27.5 mg/mL (30.45 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.1073 mL5.5367 mL11.0735 mL55.3673 mL
5 mM0.2215 mL1.1073 mL2.2147 mL11.0735 mL
10 mM0.1107 mL0.5537 mL1.1073 mL5.5367 mL
20 mM0.0554 mL0.2768 mL0.5537 mL2.7684 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy anemarsaponin B | purchase anemarsaponin B | anemarsaponin B cost | order anemarsaponin B | anemarsaponin B chemical structure | anemarsaponin B formula | anemarsaponin B molecular weight